Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Grail, Inc.

Submit data from the prevalent screening round of the NHS-Galleri trial for premarket approval

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
13 May 2025
Due
30 Jun 2026
Delivered
January 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“GRAIL plans to submit data from the prevalent screening round of the NHS-Galleri trial as part of our premarket approval application in the first half of 2026.”
  • SourceGrail, Inc. Form 8-K press release, 2025-05-13
  • FilingSEC filing index
  • Deadline as statedin the first half of 2026
  • Deadline used30 Jun 2026, the last day of the stated period
  • TypeRegulatory
  • Permanent referenceKI-C-2025-GRAL-003112
    Cite as https://keptindex.org/c/KI-C-2025-GRAL-003112/ — this address never changes.

What we found

Evidence strength A What the grades mean

Grail submitted its premarket approval application to the FDA in January 2026, which included the required data from the prevalent screening round of the NHS-Galleri trial.

  • A
    Grail, Inc. 10-K filed 2026-03-12 Regulatory filing · published 12 Mar 2026 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint 165586b8bf46
    “in January 2026, we submitted a PMA to the FDA including the full prevalent screening round analysis from the NHS-Galleri Trial” ✓ confirmed on the page

Market reaction: the shares moved -0.2% against the S&P 500 over the three sessions around the disclosure (11 Mar 2026 to 16 Mar 2026). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Submit
Deliverable
NHS-Galleri prevalent screening round data submission
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Grail, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-GRAL-003112 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.